DMAAR — Drugs Made In America Acquisition Corp.

Nasdaq · Financials · Diversified Financial Services · CIK 2028614 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
No quarterly fundamentals indexed for this ticker.

Peers — same industry

TickerNameMarket CapLastDaily %
HASI HA Sustainable Infrastructure Capital, Inc. $5.27B $41.21
DMII Drugs Made In America Acquisition II Corp. $641.46M $10.07
INV Innventure, Inc. $536.21M $6.38
BCSS Bain Capital GSS Investment Corp. $478.38M $10.20
EVAC EQV Ventures Acquisition Corp. II $477.46M $10.17

News headlines (Yahoo Finance, 1h cache)

Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) is definitely on the radar of institutional investors who own 38% of the company
2025-08-16 14:29 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.